• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

R
Raab M.	-	A TAILOR-MADE PEPTIDE-AFFINITY COLUMN TO IDENTIFY NOVEL BINDING PARTNERS FOR A CYTOPLASMIC MOTIF OF THE PLATELET INTEGRIN ALPHA IIB
Rabascio C.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Rabe E.	-	DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY
	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
Rabee H.	-	ROLE OF THYROID HORMONE ANALOGS IN ANGIOGENESIS AND THE DEVELOPMENT OF COLLATERALS IN RABBIT HIND LIMB ISCHEMIA MODEL
Rabinovich G.A.	-	GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
Rabinovich O.	-	PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS
	-	LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS
Raby A.	-	USE OF A HUMAN-DERIVED D-DIMER PREPARATION IN EXTERNAL QUALITY ASSESSMENT (EQA)
	-	D-DIMER REPORTING: WHAT'S THE PROBLEM FOR THE ELECTRONIC HEALTH RECORD? AN ONTARIO PERSPECTIVE
Rached R.	-	DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Rachman S.	-	A STUDY OF THE UTILITY OF THROMBOELASTOGRAPHY IN THE MONITORING OF ASPIRIN THERAPY
Rachmilewitz E.	-	ANTI CD20 MONOCLONAL ANTIBODIES THERAPY FOR RESISTANT ANTIPHOSPHOLIPID SYNDROME
Raddatz M.	-	DESIGN AND IN VITRO CHARACTERIZATION OF A PHOTODYNAMIC ANTICOAGULANT
Radic Antolic M.	-	INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS
Radojkovic D.	-	THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH RECURRENT PREGNANCY LOSS SERBIAN EXPERIENCE
Radosevich M.	-	TRITON X-100 IS RESPONSIBLE FOR THE LOSS OF ALPHA2-ANTIPLASMIN INHIBITORY ACTIVITY IN SOLVENT-DETERGENT TREATED PLASMA
Radossi P.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
	-	PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
Radovancevic R.	-	PLATELET AND MONOCYTE ACTIVATION IN PATIENTS UNDERGOING CIRCULATORY SUPPORT WITH LEFT VENTRICULAR ASSIST DEVICES (LVAD)
Radovancevic B.	-	PLATELET AND MONOCYTE ACTIVATION IN PATIENTS UNDERGOING CIRCULATORY SUPPORT WITH LEFT VENTRICULAR ASSIST DEVICES (LVAD)
Radtke K.P.	-	RECOMBINANT HUMAN PLASMIN PRODUCED IN LEMNA MINOR
Radu C.	-	STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
Raeburn S.	-	CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
Raff G.	-	SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO)
Raffini L.J.	-	INFERIOR VENA CAVA FILTERS IN PEDIATRIC PATIENTS
	-	THROMBOPROPHYLAXIS IN HIGH-RISK ADOLESCENT INPATIENTS
Rafii Tabrizi A.	-	HUMAN MALIGNANT CELLS EXPRESS FUNCTIONALLY ACTIVE ENDOTHELIAL PROTEIN C RECEPTOR
Ragab A.	-	ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
Ragab-Thomas J.	-	ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
Ragazzi R.	-	BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
Ragni M.V.	-	VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS
	-	SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
	-	RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD
Rago A.	-	PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS)
Rago L.	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
Ragot S.	-	INCIDENCE OF ANTITHROMBIN LEVEL ON "HEMOFILTER CIRCUIT" THROMBOSIS DURING EARLY CONTINUOUS VENOVENOUS HEMOFILTRATION IN POST CARDIOPULMONARY BYPASS PATIENTS
Rahal A.	-	FIBRINOLYTIC CAPACITY OF CORD PLASMA COMPARED TO ADULT OVER VARIOUS CONCENTRATIONS OF TPA
Rahe-Meyer N.	-	AN EVALUATION OF SINGLE PORTION REAGENT VIALS FOR ROTEM ANALYSIS
Rahgozar S.	-	BETA 2 GLYCOPROTEIN I PROTECTS THROMBIN FROM INHIBITION BY HEPARIN COFACTOR II: LOSS OF ACTIVITY BY PROTEOLYTICALLY CLIPPED BETA 2 GLYCOPROTEIN I
Raia V.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Raife T.	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
Raife T.J.	-	CORRELATIONS BETWEEN ADAMTS13 ACTIVITY AND INHIBITOR LEVELS: OBSERVATIONS AND IMPLICATIONS FOR RESOURCE UTILIZATION
	-	A CALCIUM-DEPENDENT PROTEASE CLEAVES VWF73 AT THE PEPTIDE BOND CORRESPONDING TO V1607-T1608 IN THE A2 DOMAIN
Raimondi A.	-	CRITICAL ROLE FOR CYCLOPHILIN D (CYPD) AND THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP) IN THE REGULATION OF PLATELET ACTIVATION AND THROMBOSIS
Rain J.	-	INCREASED ADHESION TO ENDOTHELIAL CELLS OF ERYTHROCYTES FROM PATIENTS WITH POLYCYTHEMIA VERA IS MEDIATED BY LAMININ ALPHA5 CHAIN AND LU/BCAM
Rajagopalan S.	-	PLATELET ACTIVATION INCREASES WITH THE SEVERITY OF PERIPHERAL ARTERIAL DISEASE: IMPLICATIONS FOR CLINICAL MANAGEMENT
	-	PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIC EVENTS IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY
Rajnavölgyi É.	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
Rajpurkar M.	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Rajpurkar M.A.	-	TISSUE PLASMINOGEN ACTIVATOR (RTPA) INDUCED FIBRINOLYSIS - STANDARDIZATION OF METHOD ON THROMBELASTOGRAPHY
	-	FIBRINOLYTIC PARAMETERS IN CHILDREN WITH NON-CATHETER RELATED DEEP VENOUS THROMBOSIS
Rajyalakshmi I.	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Rakic L.	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH RECURRENT PREGNANCY LOSS SERBIAN EXPERIENCE
	-	THE USE OF HAEMOSTASIS TESTS IN THE FOLOW UP OF A PATIENT WITH ANTITHROMBIN DEFICIENCY DURING THE PREGNANCY AND AFTER DELIVERY
	-	HAEMOPHILIA TREATMENT IN SERBIA FROM 2000 TO 2006 HOW TO REACH ONE UNIT PER CAPITA IN LOW ECONOMIC CAPACITY COUNTRY
Rakicevic L.	-	THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH RECURRENT PREGNANCY LOSS SERBIAN EXPERIENCE
	-	RISK FACTORS FOR THROMBOSIS IN CHILDREN
Rakusa M.	-	IS BIOLOGICAL VARIATION OF PLATELET FUNCTION TESTS TOO HIGH FOR RELIABLE DETECTION OF ASPIRIN RESISTANCE?
Ralevic V.	-	COMPARISON OF THE EFFECTS OF THE P2Y14 RECEPTOR AGONIST UDP-GLUCOSE AND THE EP3 RECEPTOR AGONIST SULPROSTONE ON PLATELET FUNCTION
Ram Mohan P.	-	NONINVASIVELY MEASURED AORTIC PULSE WAVE VELOCITY FOR DETECTION OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Ramackers W.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Ramenghi U.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Rameskaya G.	-	INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS
Ramirez L.M.	-	RETRIEVABLE INFERIOR VENA CAVA (IVC) FILTERS IN A TERTIARY CARE POPULATION
Ramon L.A.	-	ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION
	-	INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS
	-	FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS
Ramos R.	-	IDENTIFICATION OF VON WILLEBRAND DISEASE TYPE 2N BY VWF-FVIII BINDING ACTIVITY ASSAY IN PATIENTS AND HETEROZYGOUS CARRIERS
Ramos O.H.P.	-	CLONING, ANALYSIS AND STRUCTURAL PREDICTION OF LOSAC, A NEW HEMOLIN FROM LONOMIA OBLIQUA
Ramos C.D.	-	DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA
Ramos O.H.P.	-	AMBLYOMIN-X IN CULTURED CANCER CELLS: CITOTOXICITY AND CELL CYCLE EFFECTS
	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Ramos M.V.	-	EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
Rampado E.	-	LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
Rampini M.	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Rampinini F.	-	EVALUATION OF THE NEW KIT HEMOSIL D-DIMER HS ON SEVERAL INSTRUMENTS COMPARED TO OTHER TURBIDIMETRIC AND ELISA METHODS
Ramsay T.	-	A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
Ramschak H.	-	ENDOGENOUS THROMBIN POTENTIAL IN 3183 PARTICIPANTS OF THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
Ramsey P.	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
Ramström S.	-	PLATELET ACTIVATION VIA THROMBIN RECEPTOR PAR4 IS INVOLVED IN THE INITIATION OF THROMBIN GENERATION AND COAGULATION AND IN CLOT ELASTICITY DEVELOPMENT
	-	DIFFERENCES BETWEEN FIBRINOGEN BINDING AND RECEPTOR ACTIVATION MEASURED BY FLOW CYTOMETRY INDICATE THE EXISTENCE OF A TRANSITION STATE IN GPIIB/IIIA, RECOGNISED BY PAC-1 BUT NOT BINDING FIBRINOGEN
Ranakusuma T.	-	METABOLIC SYNDROME IN ISCHEMIC STROKE PATIENTS' CHILD
Rand K.D.	-	PROBING THE ORIGINS OF ACTIVITY ENHANCEMENT IN FACTOR VIIA (FVIIA) VARIANTS BY HYDROGEN EXCHANGE MASS SPECTROMETRY (HX-MS)
Rand M.L.	-	INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
	-	THE CANADIAN RARE INHERITED BLEEDING DISORDERS REGISTRY (RIBDR) OF COAGULATION FACTOR DEFICIENCIES AND PLATELET FUNCTION DISORDERS
	-	BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
	-	PLATELET FUNCTION THROMBOELASTOGRAPHY (PFT)
Randi M.	-	THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENT WITH LOW ADAMTS-13 ACTIVITY LEVELS BUT NO INHIBITORY AUTOANTIBODIES
	-	HOMOZYGOUS FOUR-BASE DELETION TGAG IN THE GLYCOPROTEIN IBA CODING SEQUENCE LEADING TO A PREMATURE STOP CODON IN A PATIENT WITH BERNARD-SOULIER SYNDROME
Rangarajan S.	-	UNEXPECTED FINDING OF RAISED UNDERCARBOXYLATED FII (PIVKA-II) IN FVII DEFICIENCY
	-	THROMBIN GENERATION ASSAY: CLINICAL USE IN MONITORING FVIII BYPASSING AGENT THERAPY DURING SURGERY IN A SEVERE HAEMOPHILIA A PATIENT WITH INHIBITOR
	-	PLATELET GLYCOPROTEINS: PREDICTORS OR PROGRESSION MARKERS IN CARDIOVASCULAR DISEASE?
	-	THE SIGNIFICANCE OF BREAKPOINT DELINEATION IN LARGE DELETIONS IN THE F8 GENE
	-	THE FIRST CAUSATIVE MUTATION OF HAEMOPHILIA A IDENTIFIED IN THE PROMOTER REGION OF THE FACTOR VIII GENE (F8)
	-	PROTEOMIC ANALYSIS OF PLASMA FROM HAEMOPHILIA A PATIENTS AFTER FACTOR VIII CONCENTRATE INFUSION
	-	SWITCHING PREVIOUSLY TREATED PATIENTS (PTPS) FROM PLASMA-DERIVED TO RECOMBINANT FACTOR VIII IN THE CONTEXT OF AN IMMUNOLOGICAL CHALLENGE CAN PROVOKE INHIBITOR FORMATION
	-	VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
	-	SWITCHING PREVIOUSLY TREATED PATIENTS (PTPS) FROM PLASMA-DERIVED TO RECOMBINANT FACTOR VIII IN THE CONTEXT OF AN IMMUNOLOGICAL CHALLENGE CAN PROVOKE INHIBITOR FORMATION
Ranhanath V.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Rank A.	-	GENDER AND MENSTRUAL CYCLE INFLUENCE CIRCULATING MICROPARTICLES
Rankin J.	-	COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYRO THROMBOXANE B2
Rankin A.	-	THE EFFECT OF APHERESIS ON DONORS' PLATELETS
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
Ranzurmal S.	-	CHARACTERIZATION OF ADAMTS13/FXI COMPLEX FROM PLASMA AND QUANTITATION BY ELISA IN NORMAL DONORS AND TTP PATIENTS
Rao V.	-	CORRELATION OF METABOLIC SYNDROME WITH ATHEROGENIC PHENOTYPES IN INDIAN POPULATION
Rao V.S.	-	POLYMORPHISMS IN THE IL6 GENE IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE (CAD) -INDIAN ATHEROSCLEROSIS RESEARCH STUDY
	-	HERITABILITY OF C-REACTIVE PROTEIN AND INTERLEUKIN 6 AMONG THE ASIAN INDIAN POPULATION
	-	ASSOCIATION OF CYTOMEGALOVIRUS (CMV) AND PROATHEROGENIC BIOMARKERS IN CORONARY ARTERY DISEASE (CAD)
	-	ROLE OF NOVEL LIPOPROTEIN-ASSOCIATED INFLAMMATORY MARKERS IN CORONARY ARTERY DISEASE: A PILOT STUDY
Rao V.	-	PLASMA LEVELS OF COAGULATION AND INFLAMMATORY MARKERS IN SUBJECTS AFFECTED WITH CORONARY ARTERY DISEASE
Rao D.	-	ELEVATED PLASMA GAS6 LEVELS ARE ASSOCIATED WITH CLOT BURDEN AND UNDERLYING MALIGNANCY IN DEEP-VEIN THROMBOSIS
Rao V.S.	-	PATHOGEN BURDEN AND CORONARY ARTERY DISEASE
	-	CHLAMYDIA PNEUMONIA INFECTION AND ITS RELATION TO LIPIDS AND INFLAMMATORY MARKERS IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
	-	SERUM ADIPONECTIN LEVELS & ITS CORRELATION WITH LIPIDS AND PROINFLAMMATORY MARKERS IN ASIAN INDIAN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
Rao A.K.	-	NF-B REGULATES PLATELET PLC-2 EXPRESSION: STUDIES IN HUMAN PLATELET PLC-2 DEFICIENCY
Rao V.	-	APOA1 PROMOTER POLYMORPHISMS AND THEIR ASSOCIATION WITH LIPOPROTEINS IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE (CAD)
Rao V.S.	-	APPLICATION OF THREE SEPARATE CVD PREDICTIVE SCORES AND THE RELEVANCE OF NOVEL BIOMARKERS TO RISK STRATIFICATION OF ASIAN INDIANS USING THE FRAMINGHAM RISK SCORE
	-	FVII ACTIVITY AND R353Q POLYMORPHISM IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE
	-	CONSIDERATION OF MODIFIED CUT-OFFS FOR ANTHROPOMETRIC VARIABLES IN DEFINING METABOLIC SYNDROME AMONG ASIAN INDIANS WITH CORONARY ARTERY DISEASE (CAD)
Rao M.	-	SMOOTH MUSCLE-DERIVED TISSUE FACTOR IS CRITICAL FOR ARTERIAL THROMBOSIS AFTER FECL3 INJURY
Rao A.K.	-	IMPAIRED REGULATION OF PLATELET 12-LIPOXYGENASE (ALOX12) WITH CBFA2/RUNX1 HAPLODEFICIENCY
Rao V.S.	-	CIRCULATING ANTIBODIES TO HEAT SHOCK PROTEINS AND THEIR ASSOCIATION WITH ATHEROTHROMBOTIC PHENOTYPES
Raparelli V.	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
Rapp U.	-	INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) IN NON-SURGICAL PATIENTS AT HOSPITAL ADMISSION
Rapson D.	-	DIAGNOSTIC EFFICACY OF SYSTEMATIC INVESTIGATION OF NON-VON WILLEBRAND BLEEDERS: RESULTS OF A PROSPECTIVE STUDY
	-	CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
	-	THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
Raquel M.	-	FIVE PROTHROMBOTIC POLYMORHISMS AND VENOUS THROMBOEMBOLISM
Raschi E.	-	EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
Raschke R.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
Rashkov I.	-	EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD
Rasi V.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Rask O.	-	ANTI-PROTEIN S ANTIBODIES IN CHILDREN WITH PURPURA FULMINANS AND IN HEALTHY CHILDREN FOLLOWING VARICELLA AS WELL AS IN CHILDREN WITH THROMBOSIS
	-	ESTROGEN TREATMENT OF CONSTITUTIONAL TALL STATURE IN GIRLS: RISK OF THROMBOSIS OR BLEEDING?
Raskob G.E.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Raskob G.	-	MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT
Rasmussen J.T.	-	RELATIONSHIP OF PROCOAGULANT ACTIVITY TO PHOSPHATIDYLSERINE EXPOSURE ON IMMORTALIZED ACUTE PROMYELOCYTIC LEUKEMIA CELLS
Rasmussen L.H.	-	SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
Rasmussen J.T.	-	LACTADHERIN IS MORE SENSITIVE THAN ANNEXIN-V AT DETECTING PHOSPHATIDYLSERINE EXPOSURE WITHIN PLATELETS
Rasmusson I.	-	ACTIVATION OF BLOOD COAGULATION IN AB0-COMPATIBLE BLOOD BY MULTIPOTENT MESENCHYMAL STROMAL CELLS
Rasovic N.	-	RISK FACTORS FOR THROMBOSIS IN CHILDREN
Rassoulzadegan M.	-	FACTOR XI DEFICIENCY: THREE NOVEL MUTATIONS IN IRANIAN PATIENTS
	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
	-	GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
Rastegar Lari G.	-	GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
	-	COMBINED FACTOR V AND VIII DEFICIENCY, A LARGE GROUP FROM IRAN
	-	VON WILLEBRAND DISEASE TYPES 2A MUTATION (C.4789CT, P.R1597W) IN THREE IRANIAN PATIENTS
	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
	-	A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES
	-	FACTOR XI DEFICIENCY: THREE NOVEL MUTATIONS IN IRANIAN PATIENTS
	-	THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE
Rastegarlari G.	-	FACTOR V MUTATIONS IN IRANIAN PATIENTS WITH ACTIVATED PROTEIN C RESISTANCE AND VENOUS THROMBOSIS
	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
	-	EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
	-	THROMBOSIS IN BETA THALASSEMIA MAJOR
Rastegar-lari G.	-	FACTOR VII GENOTYPE AND CLINICAL PROFILE IN 6 IRANIAN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY
Rathgen K.	-	NO INTERACTION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DIGOXIN
	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
	-	COADMINISTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DICLOFENAC HAS LITTLE IMPACT ON THE PHARMACOKINETICS OF EITHER DRUG
	-	COADMINSTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND ATORVASTATIN HAS LITTLE IMPACT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EITHER DRUG
	-	PHARMACOKINETICS AND PHARMACODYNAMICS OF DABIGATRAN ETEXILATE IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT
Ratliff H.L.	-	THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) FOLLOWING CARDIAC SURGERY: AN EMERGING SYNDROME
Ratner A.	-	THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
Rau J.C.	-	SERPINS IN THROMBOSIS, HEMOSTASIS AND FIBRINOLYSIS
	-	ENGINEERING A CHIMERIC SERINE PROTEASE INHIBITOR AS A PREVENTATIVE THERAPEUTIC FOR CARDIOVASCULAR DISEASE
Rauch R.	-	ANTICOAGULATION IN CHILDREN WITH DISTAL SPLENORENAL SHUNT (WARREN SHUNT) OR MESENTERICO- LEFT PORTAL SHUNT (REX SHUNT)
	-	ASPIRIN-RESISTANCE IN CHILDREN
Rauch U.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Rauh M.	-	INFLUENCE OF STORAGE CONDITIONS ON THROMBIN GENERATION IN PLATELET POOR PLASMA
	-	PERCUTANEOUS CATHETER EXTRACTION OF A RUPTURED PORT-A-CATH IN A SMALL CHILD WITH HAEMOPHILIA A AND F VIII INHIBITOR USING CONTINUOUS INFUSION OF RFVIIA
Rauova L.	-	THE ROLE OF HIT PLATELET FACTOR 4 ANTIGENIC COMPLEXES ON MONOCYTE SURFACES IN THE PATHOGENESIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Raut S.	-	A FLUOROGENIC THROMBIN GENERATION TEST (FTGT) FOR FACTOR VIII ACTIVITY DEMONSTRATED SUCCESS OF CELL THERAPY WITH LIVER SINUSOIDAL ENDOTHELIAL CELLS (LSEC) IN HAEMOPHILIA A MICE
Rautanen A.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Rautiainen P.	-	FRESH FROZEN PLASMA DOES NOT ATTENUATE COAGULATION ACTIVATION AFTER NEONATAL CARDIOPULMONARY BYPASS
Ravanat C.	-	EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
	-	A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
	-	REDUCED ATHEROSCLEROTIC LESIONS IN P2Y1/APOE DOUBLE KNOCKOUT MICE
	-	A MONOCLONAL ANTIBODY AGAINST PLATELET GPIBBETA INHIBITS GPIB-V-IX-DEPENDENT SIGNALLING, PROCOAGULANT ACTIVITY AND THROMBUS FORMATION UNDER FLOW PERFUSION
Ravanbod S.	-	FACTOR VII GENOTYPE AND CLINICAL PROFILE IN 6 IRANIAN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY
	-	FACTOR XI DEFICIENCY: THREE NOVEL MUTATIONS IN IRANIAN PATIENTS
	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
	-	GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
Ravel-Vilk S.	-	THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
Ravid B.	-	CAN THROMBIN GENERATION (TG) BE USED TO MONITOR RFVIIA TREATMENT: IN VIVO "MINI-PK" STUDY IN HEMOPHILIA A PATIENTS
Rawal D.	-	MULTIFACTORIAL ANALYSIS USING FOUR PHOSPHOLIPIDS TO THOROUGHLY INVESTIGATE CONTROL OF THROMBOPLASTIN PROPERTIES AND SENSITIVITIES
	-	THE IMPACT OF PHOSPHOLIPID COMPOSITION ON THE INTERFERENCE CAUSED BY THE ANTIBIOTIC DAPTOMYCIN IN THROMBOPLASTIN REAGENTS
	-	LIQUID HEPARIN ASSAY: RAPID MONITORING OF CLINICALLY USED HEPARINS
Rawlins P.	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
Rayes J.	-	EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
Raymer R.	-	EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS
Raynal N.	-	GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
	-	IDENTIFICATION OF CRITICAL RESIDUES IN A GPVI BINDING PEPTIDE
	-	CONSTITUTIVELY ACTIVE OR INACTIVE I DOMAINS AS PROBES FOR INTEGRIN BINDING TO COLLAGEN
Razmara M.	-	INCREASED PLATELET PROCOAGULANT ACTIVITY IN TYPE 2 DIABETIC PATIENTS: INHIBITION BY GPIIB/IIIA BLOCKADE
Rázsó K.	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION TREATMENT OF THERAPY-RESISTENT ACQUIRED HAEMOPHILIA WITH HIGH INHIBITOR TITER: A CASE REPORT
	-	COULD HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS BE A RARE MANIFESTATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME?
Razso K.	-	LOW DOSE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE PROPHYLAXIS OF A PATIENT WITH ACQUIRED HAEMOPHILIA AFTER UNSUCCESSFUL ERADICATION THERAPY
Razvi K.	-	HUMAN TISSUE KALLIKREINS, HK6 AND HK10 AS NOVEL BIOMARKERS FOR EPITHELIAL OVARIAN CANCER
Razzaq T.M.	-	HEPARIN TREATMENT INCREASES TYROSINE PHOSPHORYLATION OF PROTEINS IN BREAST CANCER CELLS: DIFFERENCES IN THE EFFECT OF LMWH AND UFH
Rearte B.	-	EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
Rebecca Jacob R.	-	NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
Reber G.	-	EVALUATION OF THE COAGUCHEK XS PLUS SYSTEM IN A SWISS COMMUNITY SETTING
	-	CLINICAL EVALUATION OF A NEW QUANTITATIVE HIGHLY SENSITIVE D-DIMER ASSAY FOR EXCLUSION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
	-	ANTIPHOSPHOLIPID ANTIBODIES AND TLR2 COLOCALIZED IN HUVEC ENDOSOMES
	-	DIFFERENCES IN ENDOTHELIAL CELL ACTIVATION BY IGG FROM PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME OR WITH IMMUNE THROMBOCYTOPENIC PURPURA
Rebeyka I.	-	RISK FACTORS AND OUTCOME OF THROMBOEMBOLIC EVENTS IN CHILDREN UNDERGOING CARDIAC SURGERY
	-	POINT OF CARE INR MONITORING IN CHILDREN WITH VENTRICULAR ASSIST DEVICES
Rechner A.R.	-	COMPARISON OF A NEW CARTRIDGE* FOR THE PFA-100 WITH OTHER PLATELET FUNCTION ASSAYS FOR MEASURING THE EFFECT OF CLOPIDOGREL THERAPY IN CARDIOVASCULAR PATIENTS
	-	SPECIFIC AND SENSITIVE DETECTION OF THE INHIBITION OF THE PLATELET P2Y12-RECEPTOR WITH THE PFA-100 SYSTEM USING A NEW CARTRIDGE DESIGN
Recht M.	-	REFORMULATED RECOMBINANT FACTOR IX: EFFICACY AND SAFETY IN PREVIOUSLY TREATED PATIENTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B
Redaelli R.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Reddy U.P.	-	CORONARY ARTERY BYPASS GRAFTING (CABG) IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA (ITP)
Reddy M.	-	ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS
Reding M.T.	-	DOES TESTING FOR ANTI BETA-2 GLYCOPROTEIN 1 ANTIBODIES ALTER CLINICAL PRACTICE IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME?
Redondo M.	-	MEASUREMENT OF THROMBIN GENERATION IN PATIENTS AT RISK FOR ATHEROTHROMBOSIS
Redondo P.C.	-	A ROLE FOR SNAP-25 IN THROMBIN-INDUCED PLATELET AGGREGATION
	-	ROLE OF TUBULIN-MICROTUBULES IN STORE-OPERATED CA2+ ENTRY IN HUMAN PLATELETS
	-	RELEVANCE OF CA2+ ENTRY TO PLATELET AGGREGATION BY ACTIVATION OF THROMBIN RECEPTORS
	-	REACTIVE OXYGEN SPECIES GENERATION IS REQUIRED FOR THROMBIN-INDUCED PLATELET APOPTOSIS
Reed G.L.	-	PLATELET DENSE GRANULE SECRETION ACCELERATES THE DEVELOPMENT OF ARTERIOSCLEROSIS AFTER VASCULAR INJURY
Refaai M.	-	VARIATIONS IN PLATELET FUNCTION TEST OF NORMAL INDIVIDUALS MAY AFFECT TEST INTERPRETATIONS
Regalia R.C.	-	LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
Regan C.	-	ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Regan L.	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
Reganon E.	-	INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS
	-	DYSFUNCTION ENDOTHELIAL AND ANGIOGENIC ACTIVITY IN CHRONIC HEART FAILURE: ROLE OF ORAL ANTICOAGULANT THERAPY
	-	ATORVASTATIN NEUTRALIZED THE UP-REGULATION OF THROMBOSPONDIN INDUCED BY THROMBIN IN ENDOTHELIAL CELLS
Reghis R.A.	-	SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH MIDDLE CEREBRAL ARTERIAL THROMBOSIS
Reghis A.	-	SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER
Reghis R.A.	-	ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS RYTHMATOSUS
Regina S.	-	PERFORMANCES OF A NEW ELISA (ZYMUTEST HIA) FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
	-	ASSOCIATION BETWEEN THE HOMOZYGOUS STATUS FOR THE 807T ALLELE OF ITGA2 AND RETINAL ARTERY OCCLUSION
	-	IS THE RISK OF VENOUS THROMBOEMBOLISM HIGHER WITH CYPROTERONE CONTRACEPTIVES?
Regitz-Zagrosek V.	-	EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
Regnault V.	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
	-	SIGNIFICANCE OF PLASMA SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
	-	PLATELET ACTIVATION REINFORCES THE PROCOAGULANT PHENOTYPE INDUCED BY MURINE MONOCLONAL ANTI-PHOSPHOLIPID ANTIBODIES
	-	CAN THROMBIN GENERATION BE HELPFUL TO EVALUATE THE BLEEDING PHENOTYPE IN MILD HEMOPHILIA A WITH FACTOR VIII ASSAY DISCREPANCY?
	-	INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
Rehak M.	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Rehak J.	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Reheman A.	-	ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
Rehfuss R.P.	-	CLOPIDOGREL PRODUCES DISTINCT DOSE-RESPONSE RELATIONSHIPS FOR INHIBITION OF PLATELET AGGREGATION (IPA) AND ANTITHROMBOTIC EFFICACY MEASURED IN RATS AND RABBITS
Reichel J.	-	BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
Reiff C.	-	DETERMINATION OF PLASMA COAGULATION FACTOR XIII WITH THE NOVEL FLUOROGENIC ISOPEPTIDASE ASSAY
Reimer E.	-	FREE PROTEIN S LEVELS DURING PREGNANCY
Reina C.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Reinders J.H.	-	INFLUENCE OF TESTING FOR INHERITED THROMBOPHILIA ON RECURRENCE OF VENOUS THROMBOEMBOLISM
Reinhard H.	-	HEMOPHILIA A INHIBITOR AND AUTOIMMUNNEUTROPENIA: CASE REPORT
Reinhardt C.	-	PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
Reinhöfer M.	-	EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
	-	THE VALUE OF ROTEM THROMBOLELASTOMETRY TO DETECT DISTURBED HAEMOSTASIS AND BLEEDING RISK IN ON-PUMP CARDIAC SURGERY
Reininger A.J.	-	FIBRIN-MEDIATED THROMBUS FIXATION TO ENDOTHELIUM LEADS TO MONOLAYER DISRUPTION AFTER SHEAR INDUCED THROMBUS DISLODGEMENT
Reininger A.	-	EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES
Reitsma P.H.	-	ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL
	-	PAST AND FUTURE OF GENETIC RESEARCH IN THROMBOSIS
	-	CIRCULATING MATRIX GLA PROTEIN: A POTENTIAL MARKER FOR VASCULAR COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
	-	VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
	-	`IN VIVO' TOLL-LIKE RECEPTOR 4 MRNA LEVELS ARE ASSOCIATED WITH RISK OF MYOCARDIAL INFARCTION IN MEN
	-	FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS
	-	GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY
	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
	-	DETERMINANTS OF THE ENDOGENOUS THROMBIN POTENTIAL IN A DUTCH THROMBOPHILIC FAMILY
	-	GENE EXPRESSION PROFILING IDENTIFIES C/EBP-DELTA AS A CANDIDATE REGULATOR OF ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
	-	INHIBITION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-4 PROTECTS FROM MULTI-ORGAN FAILURE IN A MURINE MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
	-	THE RISK OF RECURRENT VENOUS DISEASE ASSOCIATED WITH INFLAMMATORY MARKERS AND D-DIMER
	-	COAGULATION FACTOR XA INHIBITS CANCER CELL MIGRATION VIA LIMK1-MEDIATED COFILIN INACTIVATION
	-	FACTOR (F)XA STIMULATES FIBROPROLIFERATIVE RESPONSES IN FIBROBLASTS VIA PROTEASE ACTIVATED RECEPTOR (PAR)-2 ACTIVATION: IMPLICATIONS FOR TISSUE REMODELING
	-	GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
Rejto L.	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
Reksodiputro A.	-	CORRELATION BETWEEN A HIGHER LEVEL OF ACA WITH THE HEMOSTASIS ABNORMALITIES AMONG ADULT -THALASSEMIA
	-	ANTIPHOSPHOLIPID ANTIBODIES IN ADULT -THALASSEMIA
	-	POTENTIAL FACTORS WHICH MAY CAUSE A HIGH LEVEL OF ACA IGG AND IGM
Remijn J.A.	-	NOVEL MOLECULAR DEFECT IN THE PLATELET ADP RECEPTOR P2Y12 OF A PATIENT WITH HAEMORRHAGIC DIATHESIS
Remones V.	-	THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS
Ren Q.	-	INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Renard J.	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Renda G.	-	SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY
	-	INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
Rendina A.R.	-	INHIBITION OF MEASURED THROMBIN GENERATION IN HUMAN PLASMA BY APIXABAN: A PREDICTIVE MATHEMATICAL MODEL BASED ON EXPERIMENTALLY DETERMINED RATE CONSTANTS
Rendu F.	-	THE THROMBIN ENDOTHELIAL RECEPTORS, THROMBOMODULIN AND PAR-1, ACTIVATE EGF RECEPTOR THROUGH DISTINCT SIGNALLING
	-	HYPERCOAGULABLE STATE IN MULTIPLE MYELOMA PATIENTS TREATED OR NOT WITH THALIDOMIDE
	-	ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
	-	THIOSULFINATES MODULATE PLATELET ACTIVATION AND MONOCYTE FUNCTION BY REACTION WITH SURFACE FREE SULFHYDRYLS AND INTERNAL THIOL-CONTAINING PROTEINS
Renkens K.	-	PHASE 3 STUDY COMPARING RECOMBINANT HUMAN THROMBIN AND BOVINE THROMBIN FOR SURGICAL HEMOSTASIS
Renne T.	-	HEREDITARY ANGIOEDEMA TYPE III ARE CAUSED BY A GAIN OF FUNCTION MUTATION IN COAGULATION FACTOR XII, WHICH INCREASES VASCULAR PERMEABILITY MEDIATED BY BRADYKININ GENERATION
Renné T.	-	ROLE OF FACTOR XII IN THROMBOSIS AND INFLAMMATION
Rentala S.	-	THE UROKINASE SYSTEM REGULATES THE MOBILIZATION, HOMING AND DIFFERENTIATION OF PROGENITOR CELLS INTO ENDOTHELIAL CELLS
	-	FACTOR VII ACTIVATING PROTEASE INHIBITS VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED PROGENITOR CELL HOMING AND DIFFERENTIATION INTO ENDOTHELIAL CELLS
Renuka K.S.	-	APPLICATION OF THREE SEPARATE CVD PREDICTIVE SCORES AND THE RELEVANCE OF NOVEL BIOMARKERS TO RISK STRATIFICATION OF ASIAN INDIANS USING THE FRAMINGHAM RISK SCORE
	-	CHLAMYDIA PNEUMONIA INFECTION AND ITS RELATION TO LIPIDS AND INFLAMMATORY MARKERS IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
	-	PATHOGEN BURDEN AND CORONARY ARTERY DISEASE
	-	ROLE OF NOVEL LIPOPROTEIN-ASSOCIATED INFLAMMATORY MARKERS IN CORONARY ARTERY DISEASE: A PILOT STUDY
Reny J.L.	-	A 2 ADENINE INSERTION POLYMORPHISM IN THE FVII GENE 3'UTR IS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE BUT NOT WITH VENOUS THROMBOSIS: RESULTS OF CASE-CONTROL STUDIES
Renzi P.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
Repesse Y.	-	EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES
	-	IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
Repice C.	-	DEFIBROTIDE DIRECTLY ENHANCE THE ACTIVITY OF PLASMIN
Reséndiz J.C.	-	PERSISTENT PLATELET MICROPARTICLE FORMATION IN THE PRESENCE OF BLOCKERS OF GP IBALPHA, GPIIB/IIIA, CALCIUM CHELATORS AND ADP SCAVENGERS UNDER HIGH SHEAR STRESS
Reseski K.	-	NO INTERACTION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DIGOXIN
	-	COADMINSTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND ATORVASTATIN HAS LITTLE IMPACT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EITHER DRUG
	-	COADMINISTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DICLOFENAC HAS LITTLE IMPACT ON THE PHARMACOKINETICS OF EITHER DRUG
Reshetnyak T.M.	-	LONG-TERM OBSERVATION OF 280 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 74 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: 10-YEAR FOLLOW-UP
Reshetnyak T.	-	THE CLINICAL RELEVANCE OF PLATELET HETEROGENEITY AND ACTIVATION IN PATIENT WITH ANTIPHOSPHOLIPID SYNDROME
RETIH Group	-	SPANISH REGISTRY OF HEPARIN-INDUCED THROMBOCYTOPENIA (RETIH). PRELIMINARY DATA
Rettie A.E.	-	THE RELATIVE EFFECTS OF VKORC1 AND CYP2C9 VARIANTS ON CLINICAL OUTCOMES IN WARFARIN PATIENTS
Revel M.	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
Revel-Vilk S.	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Reverter J.C.	-	THROMBIN INDUCES MMP-10 IN HUMAN ENDOTHELIAL CELLS: PATHOPHYSIOLOGICAL IMPLICATIONS IN DISSEMINATED INTRAVASCULAR COAGULATION
	-	THE GENOTYPE BC OF THE VNTR POLIMORPHISM OF THE PLATELET GLYCOPROTEIN IB-ALPHA IS RELATED TO ASPIRIN TREATMENT FAILURE IN PATIENTS WITH ISCHEMIC STROKE
	-	VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
	-	THROMBIN GENERATION IN BEHET'S DISEASE: RELATIONSHIP WITH THROMBOSIS
Revesz T.	-	THROMBOPHILIA IN PAEDIATRIC CYSTIC FIBROSIS PATIENTS
Rey M.	-	DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION
Reyes E.	-	HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
	-	PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Reynaert A.	-	FUNCTIONAL ANALYSIS OF HUMAN PLATELETS IN NOD/SCID MICE
Reynaldo D.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Reynaud J.	-	TFPI LEVELS AND HAEMORRHAGIC EVENTS IN HAEMOPHILIC PATIENTS
	-	HIGH DOSES OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A HEMOPHILIA A PATIENT WITH INHIBITOR
Reynolds T.C.	-	PHASE 3 STUDY COMPARING RECOMBINANT HUMAN THROMBIN AND BOVINE THROMBIN FOR SURGICAL HEMOSTASIS
Reynolds J.V.	-	PROCOAGULANT EFFECTS OF NEOADJUVANT CHEMORADIATION FOR OESOPHAGEAL CANCER
Reza M.	-	STRUCTURE AND REGULATION OF A VENOM PROTHROMBIN ACTIVATOR GENE IN TROPIDECHIS CARINATUS SNAKE: A UNIQUE CIS-REGULATORY REGION RESPONSIBLE FOR THE ELEVATED EXPRESSION IN THE VENOM GLAND
Rezaie A.R.	-	THE RECEPTORS OF PROTEIN C ACTIVATION AND ACTIVATED PROTEIN C SIGNALING PATHWAYS ARE CO-LOCALIZED IN LIPID RAFTS OF ENDOTHELIAL CELLS
Rezende S.M.	-	MANAGING SUSPECTED VENOUS THROMBOEMBOLISM IN A MIXED PRIMARY AND SECONDARY CARE SETTING USING STANDARD CLINICAL ASSESSMENT AND D-DIMER IN A NON-INVASIVE DIAGNOSTIC STRATEGY
	-	ABNORMAL PATTERN FOR FVIII GENE INTRON 1 INVERSION IN ONE BRAZILIAN FAMILY
	-	DURATION OF SYMPTOMS AND D-DIMER TESTING FOR VENOUS THROMBOEMBOLISM RULING-OUT
Rhee J.	-	DISINTEGRIN SUPPRESSES HUMAN VASCULAR ENDOTHELIAL CELL MIGRATION AND INVASION BY REGULATING PLATELET ACTIVATION
Riad A.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Riba R.	-	ADIPONECTIN INDUCES AGGREGATION AND ACTIVATION OF HUMAN PLATELETS BY A PHOSPHATIDYL INOSITOL 3-KINASE-DEPENDENT MECHANISM
	-	NITRIC OXIDE INHIBITS ADHESION TO COLLAGEN BY MODULATING SENSITIVITY TO PLATELET DERIVED SECONDARY AGONISTS
	-	THROMBOSPONDIN-1 MODULATES PLATELET SENSITIVITY TO NITRIC OXIDE
Ribakova L.P.	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON THE ACTIVITY OF CATALASE
Ribba A.	-	EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
Ribeiro D.D.	-	PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS
	-	PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A) AND METILENETETRAHYDROFOLATE
	-	PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE
	-	HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
Ribeiro M.E.	-	FACTOR V LEIDEN AS A THROMBOPHILIA'S MARKER IN LIVER TRANSPLANTATION - AN EVALUATION
Ribeiro D.D.	-	APO B ECORI AND INSERTION/DELETION POLYMORPHISMS IN BRAZILIAN YOUNG PATIENTS WITH ISQUEMIC STROKE
	-	SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS
Ribes C.	-	EFFICACY OF FACTOR XIII SUBSTITUTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
Riboldi P.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Ricart J.M.	-	FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS
Ricciardi G.	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
Ricci-Silva M.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Rice C.M.	-	A NOVEL INTEGRATED DATABASE AS REPOSITORY FOR GENETIC AND CLINICAL DATA IN ATHEROTHROMBOSIS STUDIES
	-	DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
Rice C.	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
Rice K.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Rice A.	-	ASSESSMENT OF PLATELET FUNCTION IN NORMAL ADULTS: RISTOCETIN-INDUCED PLATELET AGGREGATION (RIPA)
Rice G.I.	-	PROTEOLYTIC CLEAVAGE OF ACTIVATED COAGULATION FACTOR XIII BY PLASMIN: NOVEL MECHANISM OF FACTOR XIII REGULATION?
Richard B.	-	PROTEASE NEXIN-1 AND THROMBOMODULIN FORM COMPLEXES WITH A HIGHLY POTENT ANTI-THROMBIN ACTIVITY
Richardson P.D.	-	EFFECT OF PRESENCE OR ABSENCE OF RED CELLS ON EARLY GROWTH RATES OF PLATELET MURAL THROMBI
Richman P.B.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Richter H.	-	ON DEMAND TREATMENT AND CONTINUOUS PROPHYLAXIS OF ADULT HAEMOPHILIA A PATIENTS: A COMPARATIVE RETROSPECTIVE DATA ASCERTAINMENT
Rickard M.	-	VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
Rico M.C.	-	ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS
	-	THROMBOSPONDIN-1 (TSP1) PROMOTES THROMBIN GENERATION ON THE SURFACE OF FIBROBLASTS (HS-68) AND INDUCES UPREGULATION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE AND PROTEIN EXPRESSION
Riddell A.	-	THROMBIN GENERATION TEST (TGT) AND ROTATIONAL THROMBOELASTOGRAPHY (ROTEM) AND ITS USE IN ASSESSING SEVERE HAEMOPHILIA A PHENOTYPE
	-	THROMBIN GENERATION & ROTEM TESTS IN PREGNANCY: POTENTIAL FOR MONITORING ADEQUACY OF LOW MOLECULAR WEIGHT HEPARIN ADMINISTRATION
Riedel T.	-	NEW HEREDITARY DYSFIBRINOGENEMIA AALPHA ASN106ASP ASSOCIATED WITH THROMBOSIS
Rieder M.J.	-	THE RELATIVE EFFECTS OF VKORC1 AND CYP2C9 VARIANTS ON CLINICAL OUTCOMES IN WARFARIN PATIENTS
Rieger M.	-	IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
	-	PLATELET FUNCTION UNDER HIGH SHEAR CONDITION CORRELATES WITH CLINICAL ESTIMATION OF HEMORRHAGE IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIA
	-	IGA CLASS OF AUTOANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Riesenfeld J.	-	ENHANCED HEPARIN BINDING AFFINITIES INCREASE THE EFFICIENCIES AT WHICH THE BETA-ANTITHROMBIN III ISOFORM AND A RECOMBINANT ATIII VARIANT LOAD ONTO PENTASACCHARIDE-BEARING SURFACES UNDER FLOW
Riess H.	-	PROSPECTIVE, RANDOMIZED OPEN TRIAL OF ENOXAPARIN IN PATIENTS WITH ADVANCED PANCREATIC CANCER UNDERGOING FIRST-LINE CHEMOTHERAPY
Riess H.B.	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
	-	CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS
	-	DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY
Riewald M.	-	ACTIVATED PROTEIN C LEADS TO CELL SURFACE ACCUMULATION OF CLEAVED PAR1 AND SUPPORTS PROTECTIVE SIGNALING EVEN IN THE PRESENCE OF THROMBIN
	-	ROLE OF PAR1 IN PROTECTIVE SIGNALING BY ACTIVATED PROTEIN C IN SYSTEMIC INFLAMMATION
	-	CELLULAR FUNCTIONS OF APC
Righini M.	-	MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
	-	IS IT WORTH DIAGNOSING AND TREATING DISTAL DEEP VEIN THROMBOSIS? NO
	-	INFLUENCE OF AGE ON THE COST EFFECTIVENESS OF DIAGNOSTIC STRATEGIES FOR SUSPECTED PULMONARY EMBOLISM
Rigo B.	-	STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
	-	THE OCCURRENCE OF FACTOR V LEIDEN MUTATION IN HUNGARIAN HELLP SYNDROME PATIENTS
Rigo L.	-	SEVERE SPONTANEOUS ARTERIAL THROMBOTIC MANIFESTATIONS IN PATIENTS WITH INHERITED HYPO- AND AFIBRINOGENEMIA
Rihal C.	-	DE NOVO ATOMIC FORCE MICROSCOPY OF INTRACORONARY THROMBUS: NEW INSIGHTS INTO FIBRIN CLOT ARCHITECTURE AND IMPLICATIONS FOR FIBRINOLYSIS
Rijken D.C.	-	ALPHA-1-ANTITRYPSIN IS THE MOST ABUNDANT PROTEIN NON-COVALENTLY BOUND TO THE FIBRIN MATRIX OF A PLASMA CLOT
Riley M.A.	-	THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) FOLLOWING CARDIAC SURGERY: AN EMERGING SYNDROME
Rimoldi V.	-	CHARACTERIZATION OF THE F11 ALTERNATIVE SPLICING PATTERN: IDENTIFICATION OF A NOVEL COAGULATION FXI ISOFORM
Rinaldi L.	-	PROSTACYCLIN IMPROVES TRANSCORONARY MYOCARDIAL DELIVERY OF ADIPOSE TISSUE-DERIVED STROMAL CELLS
Rio B.	-	ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Riondino S.	-	PERSISTENT TXA2 PRODUCTION IN PATIENTS CHRONICALLY TREATED WITH ASPIRIN: RESIDUAL COX-1 ACTIVITY OR COX-2 ACTIVATION?
	-	CAMP-INDUCED INHIBITION OF CA2+ MOBILIZATION IS REVERSED BY TYROSINE PHOSPHORYLATION OF IP3R IN PLATELETS
Ripart-Neveu S.	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
Ripoche J.	-	HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS
Rischewski J.	-	THE Y2561 ALLELE OF A COMMON POLYMORPHISM IN THE C1 DOMAIN OF VON WILLEBRAND FACTOR APPEARS AS A NOVEL RISK FACTOR FOR MYOCARDIAL INFARCTION
Risso F.	-	PRETERM BIRTH AND FETAL GROWTH RESTRICTION HAVE AN IMPACT ON ELASTIC AND COLLAGENIC STRUCTURES OF HUMAN UMBILICAL ARTERIES
Rittich [Scaron].	-	USE THROMBIN GENERATION ASSAY AND THROMBELASTOGRAPHY IN MONITORING OF RESPONSE TO DDAVP IN PATIENTS WITH TYPE 1 AND 2A VON WILLEBRAND DISEASE
Rittich S.	-	Detection of nonmuscle myosin-IIA, inclusions in neutrophils, D-variant of fibulin-1 and mutations within MYH9 gene in patients with MYH9-ralated disorders
Rivard G.	-	EFFICACY OF A FVIII/VWF CONCENTRATE AS REPLACEMENT THERAPY IN PREVENTING EXCESSIVE BLEEDING IN SUBJECTS WITH CONGENITAL VON WILLEBRAND DISEASE (VWD) WHO UNDERWENT SURGICAL OR INVASIVE PROCEDURES
Rivard G.E.	-	IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS
Rivas-Gonzalez M.R.	-	A PROSPECTIVE STUDY OF PATIENTS WITH CANCER WITH A SHORT ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) IN THE ABSENCE OF THROMBOSIS
Rivera J.	-	FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA
Rivera P.	-	LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
Rivera J.	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
	-	JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
	-	BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
	-	PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION
Riveros D.	-	ASSESSMENT OF THE EFFECTIVENESS AND SECURITY OF HOME TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW MOLECULAR WEIGHT HEPARIN IN ARGENTINA
Rivolta G.F.	-	A SUCCESSFUL IMMUNOMODULATION-ITI RESCUE IN SEVERE HAEMOPHILIA A WITH HIGH RESPONDER INHIBITOR
Rivron-Guillot K.	-	RETRIEVABLE VENA CAVA FILTERS FOR SECONDARY PREVENTION OF PULMONARY EMBOLISM IN ORTHOPAEDIC SURGERY
Rizk A.	-	PROTHROMBIN AND FACTOR V LEIDEN GENE POLYMORPHISM IN PATIENTS WITH DVT
Rizzo M.	-	HOME CLINICAL ASSISTANCE: SICILIAN SURVEY ON THE HCA SUPPORT FOR THE MANAGEMENT OF THE PROPHYLAXIS IN PAEDIATRIC HAEMOPHILIAC PATIENTS
Rizzotto L.	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
	-	INTRACELLULAR EVALUATION OF ER TARGETING ELUCIDATES A MILD FORM OF INHERITED COAGULATION DEFICIENCY
Rizzuto R.	-	INTRACELLULAR EVALUATION OF ER TARGETING ELUCIDATES A MILD FORM OF INHERITED COAGULATION DEFICIENCY
Robb L.M.	-	IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Robben J.H.	-	FUNCTIONALITY OF THE VASOPRESSIN 2 RECEPTOR VARIATION G12E AS MODIFIER OF VON WILLEBRAND FACTOR AND FACTOR VIII LEVELS
Robert S.	-	COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES
Robert A.	-	A NEW MODE OF PROTHROMBIN TIME (PT) REPORTING SPECIFIC FOR LIVER DISEASES
Robert S.	-	STANDARDIZATION OF MICROPARTICLE COUNTING USING FLOW CYTOMETRY: NEW OPTIONS AND TOOLS FOR THE CONTROL OF CRITICAL INSTRUMENT SETTINGS
	-	THROMBIN ACTIVITY PROFILE: A POWERFUL EX VIVO SCREENING TEST FOR THE DEVELOPMENT OF ANTICOAGULANT DRUGS
Robert A.	-	EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
	-	A SCREENING TEST FOR THROMBOSIS RISK FACTORS AS A MARKER OF LIVER FIBROSIS IN CHRONIC HEPATITIS C
Roberts W.	-	THROMBOSPONDIN-1 MODULATES PLATELET SENSITIVITY TO NITRIC OXIDE
Roberts J.R.	-	BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
	-	THROMBIN BINDING TO GLYCOPROTEIN IB ALPHA ON PLATELETS INVOLVES EXOSITE I
Roberts P.L.	-	REMOVAL OF HUMAN PARVOVIRUS B19 FROM FACTOR IX BY VIRUS FILTRATION
Roberts J.R.	-	MODULATION OF VON WILLEBRAND A1 DOMAIN FUNCTION BY THE HOMOLOGOUS DOMAINS A2 AND A3
Roberts A.W.	-	PROGRAMMED ANUCLEAR CELL DEATH DELIMITS PLATELET LIFE SPAN
Roberts C.	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
Roberts J.	-	GLYCOPROTEIN IB ALPHA BINDS THROMBIN VIA TO BOTH EXOSITE I AND II OF THROMBIN
Roberts H.R.	-	RESTORING INITIAL THROMBIN GENERATION DOES NOT NORMALIZE CUTANEOUS WOUND HEALING IN HEMOPHILIA B
Roberts J.R.	-	PROTEOLYSIS-INDEPENDENT ENHANCEMENT OF ARTERIAL THROMBOSIS MEDIATED BY THROMBIN BINDING TO GLYCOPROTEIN IB AND VON WILLEBRAND FACTOR
Roberts H.R.	-	HIGH DOSE FACTOR VIIA CORRECTS THROMBIN GENERATION IN A MODEL OF DILUTIONAL COAGULOPATHY
Roberts C.	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
Roberts W.	-	NITRIC OXIDE INHIBITS ADHESION TO COLLAGEN BY MODULATING SENSITIVITY TO PLATELET DERIVED SECONDARY AGONISTS
Roberts J.R.	-	ROLE OF DISTINCT AMINO ACID RESIDUES IN THE INTERACTION OF SOLUBLE OR SURFACE-BOUND VON WILLEBRAND FACTOR A1 DOMAIN WITH PLATELETS
Robertson L.	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
Robins S.J.	-	INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
Robinson M.	-	CLINICAL FACTORS INFLUENCING RETURN TO NORMAL HEMOSTASIS AFTER STOPPING WARFARIN
Robinson D.K.	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
	-	THE LEECH PRODUCT SARATIN IS A POTENT INHIBITOR OF PLATELET INTEGRIN ALPHA2BETA1 AND VWF BINDING TO COLLAGEN
Robinson E.A.	-	HEPARIN INDUCED THROMBOCYTOPENIA: COMPLIANCE WITH GUIDELINES IN A LARGE COMMUNITY HOSPITAL
Robinson-Cohen C.	-	THE EFFECT OF ANTICOAGULANTS ON CANCER RISK AND SURVIVAL: SYSTEMATIC REVIEW
Robles L.	-	HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
	-	IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
	-	THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Roborel de Climens A.	-	CONVENIENCE OF THE NEW LONG-ACTING ANTICOAGULANT IDRAPARINUX (IDRA) VERSUS VITAMIN K ANTAGONIST (VKA) IN PATIENTS WITH DEEP VENOUS THROMBOSIS (DVT)
Robson T.	-	BLOOD-BORNE BUT NOT ENDOTHELIAL CD40 PROMOTES EXPERIMENTAL LUNG METASTASIS
	-	THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Robson S.	-	INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD
Robson T.	-	PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Rocca B.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Rocco M.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
	-	DIFFERENT INTEGRINS, DIFFERENT STATES, DIFFERENT SHAPES?
Rocha E.	-	THROMBOPROPHYLAXIS WITH BEMIPARIN STARTED 6 HOURS AFTER HIP OR KNEE REPLACEMENT SURGERY: REVIEW OF CLINICAL AND POSTMARKETING EXPERIENCE
	-	CLINICAL OUTCOMES DURING BEMIPARIN POST-MARKETING OBSERVATIONAL STUDIES ON PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
Rochela L.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Rocino A.	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
Rodeghiero F.	-	SEVERE SPONTANEOUS ARTERIAL THROMBOTIC MANIFESTATIONS IN PATIENTS WITH INHERITED HYPO- AND AFIBRINOGENEMIA
	-	TEN NOVEL MUTATIONS IN FXI GENE
	-	ALTERED BINDING OF PURIFIED TYPE 2M VICENZA VON WILLEBRAND FACTOR TO PLATELET RECEPTOR ALPHAIIBBETA3 AND GPIB-V-IX COMPLEX
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	ANTITHROMBIN DEFICIENCY IN THE GENERAL POPULATION IS RARELY DUE TO AT GENE MUTATIONS, WHICH ARE MAINLY REPRESENTED BY ALA384SER MUTATION
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
	-	A BAYESIAN APPROACH TO THE DIAGNOSIS OF TYPE 1 VON WILLEBRAND DISEASE
	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
	-	HOW TO ESTIMATE BLEEDING RISK IN MILD BLEEDING DISORDERS
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
Roder H.	-	DOMAIN 5 PEPTIDES OF HIGH MOLECULAR MASS KININOGEN UNDERGO CONFORMATIONAL CHANGES INDUCED BY ZINC
Rodger M.A.	-	D-DIMER WHILE ON ORAL ANTICOAGULANTS (OAC) IS ASSOCIATED WITH SUBSEQUENT RECURRENT VENOUSTHROMBOEMBOLISM OFF OF OAC IN WOMEN BUT NOT MEN
	-	A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA
	-	RISK STRATIFICATION FOR VENOUS THROMBOEMBOLISM RECURRENCE
	-	A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
	-	PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
	-	REVERSE: RECURRENT VENOUS THROMBOEMBOLISM (VTE) RISK STRATIFICATION EVALUATION: A PROSPECTIVE COHORT STUDY TO DEVELOP A CLINICAL PREDICTION RULE TO IDENTIFY LOW RISK PATIENTS WHO CAN DISCONTINUE ORAL ANTICOAGULANTS (OAC) 5-7 MONTHS AFTER TREATMENT FOR IDI
	-	SECULAR TRENDS IN STUDIES EVALUATING VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
	-	FACTOR V LEIDEN (FVL) AND PROTHROMBIN GENE VARIANT (PGV) MAY BE ONLY WEAKLY ASSOCIATED WITH PLACENTA MEDIATED PREGNANCY COMPLICATIONS: A LARGE PROSPECTIVE COHORT STUDY
	-	HYPERCHOLESTEROLEMIA IS STRONGLY ASSOCIATED WITH RISK OF RECURRENT VTE IN WOMEN TREATED FOR 5-7 MONTHS WITH ORAL ANTICOAGULANTS (OAC) FOR IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE)
	-	INFLUENCE OF GENDER AND AGE ON RISK OF RECURRENT VENOUSTHROMBOEMBOLISM (VTE) IN PATIENTS WITH IDIOPATHIC VTE TREATED 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY
	-	DEFINING BENEFIT-RISK TRADEOFF VALUES FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
Rodger M.	-	LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE
Rodger M.A.	-	IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA - A CROSS-SECTIONAL SURVEY
	-	SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE) EVALUATION (SOME TRIAL): A PROSPECTIVE PILOT COHORT STUDY USING COMPREHENSIVE ABDOMEN/PELVIS COMPUTED TOMOGRAPHY (CCT)
	-	INTER-OBSERVER RELIABILITY OF MEASURES TO ASSESS THE POST-THROMBOTIC SYNDROME (PTS)
	-	POST-THROMBOTIC SYNDROME (PTS) SIGNS AND SYMPTOMS AT THE TIME OF DISCONTINING 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY FOR IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE) IS ASSOCIATED WITH SUBSEQUENT RECURRENT VTE
	-	RESIDUAL VENOUS THROMBOSIS AFTER 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY AS A PREDICTOR OF SUBSEQUENT RECURRENT VENOUS THROMBOEMBOLISM VTE
Rodgers G.M.	-	A COMPARISON OF TWO COMMERCIAL ADAMTS-13 ACTIVITY ASSAYS WITH A REFERENCE LABORATORY METHOD
Rodgers S.E.	-	LABORATORY DIAGNOSIS OF THE DISCREPANT PHENOTYPE OF MILD HAEMOPHILIA A USING A MODIFIED CHROMOGENIC FACTOR VIII ASSAY
Roditi G.H.	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
Rodolphe B.	-	PULMONARY EMBOLISM DIAGNOSTIC TOOLS IN FRENCH EMERGENCY DEPARTMENTS: AVAILABILITY INCREASES BUT PHYSICIAN KNOWLEDGE REMAINS POOR
Rodriguez R.B.	-	INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS
Rodriguez J.A.	-	EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK
Rodriguez I.	-	PLATELET ADHESION STUDIES ON NANOSTRUCTURED POLY (LACTIC-CO-GLYCOLIC ACID) CARBON NANOTUBE COMPOSITE
Rodriguez N.I.	-	FAILURE OF IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA B PATIENTS WITH C, T 6460 NONSENSE MUTATION
Rodriguez E.V.	-	CRYOPRECIPITATE-REMOVED PLASMA AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B
Rodriguez J.A.	-	CYTOKINE-INDUCED MONOCYTE-ENDOTHELIAL CELL INTERACTIONS: EFFECT ON PAI-1 LEVELS
	-	THROMBIN INDUCES MMP-10 IN HUMAN ENDOTHELIAL CELLS: PATHOPHYSIOLOGICAL IMPLICATIONS IN DISSEMINATED INTRAVASCULAR COAGULATION
Rodriguez Huerta A.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION
Rodriguez-Maldonado E.	-	EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS
Rodríguez-Mañas L.	-	BEMIPARIN THROMBOPROPHYLAXIS IN ELDERLY MEDICAL PATIENTS: THE "ANCIANOS" STUDY
Rodriguez-Merchan E.C.	-	SURGERY IN HEMOPHILIA PATIENTS WITH INHIBITORS: REPORT OF 91 SURGICAL PROCEDURES
	-	RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Roelofs J.J.T.H.	-	UPAR IS AN IMPORTANT MODULATOR OF TUBULAR REPAIR AFTER RENAL ISCHEMIA REPERFUSION INJURY
Roemisch J.	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
	-	VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
	-	A PHARMACEUTICALLY LICENSED SOLVENT/DETERGENT (S/D) TREATED PLASMA AND A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT IN TTP AND HUS: QUANTIFICATION OF ADAMTS13 AND FACTOR H LEVELS
	-	PRION PROTEIN REMOVAL DURING MANUFACTURING OF HIGH-PURITY VWF/FVIII CONCENTRATES
	-	PRODUCT FEATURES OF THE NOVEL GENERATION VWF/FVIII CONCENTRATE IN A COMPARISON WITH FIRST GENERATION PRODUCTS
	-	PRION PROTEIN (PRPSC) REMOVAL BY CHROMATOGRAPHY PURIFICATION AND NANOFILTRATION OF FIXS AND PCC
	-	THROMBIN GENERATION CAPACITY IS IMPAIRED IN METHYLENE-BLUE (MB) TREATED PLASMA UNITS COMPARED TO SINGLE-DONOR FFP, A PHARMACEUTICALLY LICENSED COAGULATION ACTIVE AND SOLVENT-DETERGENT (S/D) TREATED PLASMA PRODUCT AND A UNIVERSALLY APPLICABLE S/D-PLASMA UN
Rogachevskiy O.V.	-	RECOMBINANT COAGULATION FACTOR VIIA IN THERAPY OF MASSIVE POST-PARTUM BLEEDING AT PATIENT WITH IDIOPATHIC THROMBOCYTOPENIA (ITP)
Roger S.	-	PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
Rogers J.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Rognum T.O.	-	FREQUENCY AND TIME OF ONSET OF ACUTE MYOCARDIAL INFARCTION IN SUDDEN UNEXPECTED DEATHS IN A FORENSIC AUTOPSY MATERIAL
Rogolino A.	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	QUALITY OF OAT AND VTE RECURRENCE
	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
	-	RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
Rogus J.	-	INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
Rohatgi S.	-	Common thrombophilias in 85 Indian patients with arterial thrombosis
Rohlfing W.	-	DATABASE MANAGEMENT SYSTEM FOR A HAEMOPHILIA COMPREHENSIVE CARE CENTRE
Røjkjær R.	-	FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Rojkjaer R.	-	COMBINED EFFECTS OF RFVIIA AND RFXIII ON CLOT FORMATION AND STABILITY IN PLASMA AND BLOOD FROM NORMAL DONORS AND FROM THROMBOCYTOPENIC PATIENTS
Rolandi G.	-	OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
Roldán V.	-	BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
Roldan V.	-	TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE
	-	ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY
Roldán V.	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
	-	GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
Roldan V.	-	ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION
	-	INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION
Rolf N.	-	INFLUENCE OF DESMOPRESSIN ON HEMOSTASIS IN CHILDREN WITH BLEEDING DISORDERS
Román A.	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
Román M.A.	-	ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
Roman M.I.	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
Román M.A.	-	PROPHYLAXIS WITH RECOMBINANT FVIIA
	-	SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
Roman M.A.	-	NEW THERAPEUTIC APPROACH IN ACQUIRED HEMOFILIA
Román M.A.	-	PRIMARY PROPHYLAXIS WITH RECOMBINANT FACTOR VIIA IN A PATIENT WITH HAEMOPHILIA A AND INHIBITOR
Romani de Wit T.	-	VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
Romanko K.	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Romano E.	-	PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
	-	CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
	-	MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
Romanowski V.	-	IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
Romay-Penabad Z.	-	EFFECTS OF AN INHIBITOR OF NUCLEAR FACTOR-KAPPA B (NF-KB) ON THROMBOGENIC PROPERTIES OF ANTIPHOSPHOLIPID ANTIBODIES IN VIVO
	-	THE TRANSCRIPTION FACTOR EGR-1 PLAYS A CRITICAL ROLE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS
	-	ROLE OF P38 MITOGEN ACTIVATED PROTEIN KINASE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS AND ENDOTHELIAL CELL ACTIVATION
	-	A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO
Rombouts E.K.	-	DAILY VITAMIN K SUPPLEMENTATION IMPROVES STABILITY OF TREATMENT WITH VITAMIN K ANTAGONISTS
Romero A.	-	GENETIC THROMBOPHILIA AND THROMBOSIS OF CEREBRAL VENOUS SINUSES
Romero-Garrido J.A.	-	RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Romijn F.P.H.	-	CIRCULATING MICROPARTICLE (MP)-ASSOCIATED TISSUE FACTOR (TF) ACTIVITY AND THROMBOSIS IN CANCER PATIENTS
Römisch J.	-	A BIOCHEMICAL COMPARISON OF A PHARMACEUTICALLY LICENSED S/D TREATED PLASMA WITH A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT AND SINGLE-DONOR FFPS SUBJECTED TO METHYLENE-BLUE DYE AND WHITE-LIGHT TREATMENT
Rommens J.M.	-	IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS
Romualdi E.	-	SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY
	-	METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY
	-	THYROID DISEASES AND THE COAGULATION SYSTEM: A SYSTEMATIC REVIEW
Romundstad P.R.	-	HOMOCYSTEINE AND RISK FOR VENOUS THROMBOSIS IN A POPULATION-BASED PROSPECTIVE STUDY (HUNT2)
Roodt J.	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Roodt J.P.	-	A NOVEL COMPLETE HIGH SHEAR RATE ARTERIAL THROMBOSIS AND BLEEDING MODEL IN BABOONS
Roodt J.	-	THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS
Rooke T.W.	-	IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
Röpke M.	-	IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Rosa J.	-	HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS
Rosa A.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
Rosado J.A.	-	A ROLE FOR SNAP-25 IN THROMBIN-INDUCED PLATELET AGGREGATION
	-	REACTIVE OXYGEN SPECIES GENERATION IS REQUIRED FOR THROMBIN-INDUCED PLATELET APOPTOSIS
	-	ROLE OF TUBULIN-MICROTUBULES IN STORE-OPERATED CA2+ ENTRY IN HUMAN PLATELETS
	-	RELEVANCE OF CA2+ ENTRY TO PLATELET AGGREGATION BY ACTIVATION OF THROMBIN RECEPTORS
Rosales-Manoatl M.	-	A PROSPECTIVE STUDY OF PATIENTS WITH CANCER WITH A SHORT ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) IN THE ABSENCE OF THROMBOSIS
Rosamond W.	-	COAGULATION FACTORS IX - XIII AND RISK OF FUTURE VENOUS THROMBOSIS: THE LONGITUDINAL INVESTIGATION OF THROMBOEMBOLISM ETIOLOGY (LITE)
Rosano C.	-	DIFFERENT INTEGRINS, DIFFERENT STATES, DIFFERENT SHAPES?
Rosas P.	-	SENSITIVITY TO ACTIVATED PROTEIN C (APC) IS INCREASED DURING THE SECRETORY PHASE OF THE MENSTRUAL CYCLE
Rose P.	-	WHAT DO ELEVATED D-DIMER LEVELS MEAN IN PATIENTS WITHOUT VENOUS THROMBOSIS (VTE)?
	-	WHICH PATIENTS WITH VENOUS THROMBOSIS DO NOT REQUIRE SCREENING FOR MALIGNANCY? A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH VTE AT MINIMAL RISK OF MALIGNANCY
	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Rosén P.	-	A CHROMOGENIC METHOD FOR DETERMINATION OF FIXA IN PURIFIED PREPARATIONS
Rosén S.	-	A CHROMOGENIC METHOD FOR DETERMINATION OF FIXA IN PURIFIED PREPARATIONS
Rosenberg N.	-	PLATELET GPIIBIIIA-FIBRINOGEN BINDING ACTIVITY IS INCREASED BY ALLICIN (A THIOL-REACTIVE REAGENT)
	-	SPECIFIC CYSTEINE RESIDUES IN BETA3 ARE ESSENTIAL FOR DISULFIDE BOND EXCHANGE- DEPENDENT OR -INDEPENDENT PATHWAYS OF ALPHAIIBBETA3 ACTIVATION
	-	A NATURAL MUTATION AND SPECIFIC ARTIFICIAL DELETIONS IN THE BETA3 CYTOPLASMIC TAIL PREVENT ANTIBODY-MEDIATED ACTIVATION OF INTEGRIN ALPHAIIB-BETA3
	-	IS BETA3-ARG261 RESPONSIBLE FOR THE EXCLUSIVE BINDING OF ALPHAIIB TO BETA3?
	-	ALPHA V SUPPRESSION BY SIRNA AUGMENTS OR INHIBITS VEGF AND VEGFR-2 EXPRESSION DEPENDING ON THE ORIGIN OF ENDOTHELIAL CELLS
	-	TWO APPARENT MISSENSE MUTATIONS IN EXONS OF THE FACTOR XI GENE CAUSE SPLICING DEFECTS DISPLAYING A NOVEL MECHANISM FOR MUTATIONS IN CLOTTING FACTORS
	-	THREE RESIDUES (L284, I290, Y329) IN THE APPLE 4 DOMAIN OF FACTOR XI (FXI) ARE ESSENTIAL FOR COVALENT DIMERIZATION OF FXI SUBUNITS
Rosencher N.	-	LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
	-	DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT
Rosendaal F.R.	-	PREVENTION OF TRAVELLERS' THROMBOSIS: A COMPARISON OF THREE INTERVENTIONS THAT PROMOTE VENOUS OUTFLOW
	-	HAPLOTYPES OF THE C-REACTIVE PROTEIN GENE, PLASMA CRP LEVELS AND THE RISK OF MYOCARDIAL INFARCTION IN MEN
Rosendaal F.	-	NUTRITIONALLY INDUCED OBESITY REDUCES THE ARTERIAL THROMBOTIC TENDENCY OF FACTOR V LEIDEN MICE
Rosendaal F.R.	-	THE RISK OF RECURRENT VENOUS DISEASE ASSOCIATED WITH INFLAMMATORY MARKERS AND D-DIMER
	-	MINOR LEG INJURIES INCREASE VENOUS THROMBOTIC RISK FIVE FOLD
	-	SNPS NEAR THE ESTROGEN SULFOTRANSFERASE GENE SULT1E1 AND THE RISK OF VENOUS THROMBOSIS IN RELATION TO ORAL CONTRACEPTIVE USE
	-	MAJOR CHANGES IN THE DIAGNOSTIC WORK-UP OF PULMONARY EMBOLISM BETWEEN 1999 AND 2004
	-	FUNCTIONALITY OF THE VASOPRESSIN 2 RECEPTOR VARIATION G12E AS MODIFIER OF VON WILLEBRAND FACTOR AND FACTOR VIII LEVELS
	-	GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
	-	POLYMORPHISMS IN COAGULATION FACTORS ARE NOT ASSOCIATED WITH THE RISK OF RECURRENT MAJOR ARTERIAL CARDIOVASCULAR EVENTS IN MEN AFTER A FIRST MYOCARDIAL INFARCTION: RESULTS OF 11 YEARS FOLLOW-UP
	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
Rosendaal F.	-	BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES
Rosendaal F.R.	-	SELECTIN HAPLOTYPES AND THE RISK OF VENOUS THROMBOSIS; INFLUENCE OF LINKAGE DISEQUILIBRIUM WITH THE FACTOR V LEIDEN MUTATION
	-	TRENDS IN THE DIAGNOSTIC WORK-UP OF DEEP VENOUS THROMBOSIS OF THE LEG BETWEEN 1999 AND 2004
	-	HYPOFIBRINOLYSIS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MEN
	-	DAILY VITAMIN K SUPPLEMENTATION IMPROVES STABILITY OF TREATMENT WITH VITAMIN K ANTAGONISTS
	-	INFLUENCE OF TESTING FOR INHERITED THROMBOPHILIA ON RECURRENCE OF VENOUS THROMBOEMBOLISM
	-	AIR TRAVEL AND VENOUS THROMBOSIS: A SYSTEMATIC REVIEW
	-	PREDICTION OF BLEEDING AND THROMBOTIC EVENTS IN PATIENTS WITH MECHANICAL HEART VALVE PROSTHESES TREATED WITH ORAL ANTICOAGULANTS
	-	LONG DISTANCE TRAVEL AND RISK OF VENOUS THROMBOSIS: EFFECT OF PROCOAGULANT FACTOR LEVELS
	-	FACTOR IX GENE VARIANTS AND THE RISK OF VENOUS THROMBOSIS
	-	SELF-RATED HEALTH PREDICTS MORTALITY IN PATIENTS WITH HEMOPHILIA
	-	ELEVATED ENDOGENOUS THROMBIN POTENTIAL (ETP) IS ASSOCIATED WITH AN INCREASED RISK OF A FIRST DEEP VENOUS THROMBOSIS BUT NOT WITH RECURRENCE
	-	INVESTIGATING POSSIBLE MECHANISMS OF THE FACTOR V LEIDEN PARADOX
Rosendaal F.F.	-	VENOUS THROMBOSIS IN THE ELDERLY
Rosendaal F.R.	-	THE ABSOLUTE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL: EFFECT OF RISK FACTORS AND BEHAVIOUR DURING FLIGHTS
	-	ASSOCIATION OF BLOOD PRESSURE AND FACTOR VIII IN LEIDEN THROMBOPHILIA STUDY (LETS) AND CARDIOVASCULAR HEALTH STUDY (CHS)
	-	SYNERGISTIC EFFECTS OF HYPOFIBRINOLYSIS AND GENETIC AND ACQUIRED RISK FACTORS IN VENOUS THROMBOSIS
	-	RECURRENT VENOUS THROMBOSIS OF THE UPPER EXTREMITY
	-	AQUAPORIN 2 GENE VARIATIONS, LEVELS OF VON WILLEBRAND FACTOR AND FACTOR VIII AND THE RISK OF VENOUS THROMBOSIS
	-	SMOKING INCREASES THE RISK OF VENOUS THROMBOSIS
	-	A CODING SNP AT THE GPI-ATTACHMENT SITE IN THE TFPI-BETA-SPECIFIC EXON IS ASSOCIATED WITH TFPI LEVELS
	-	A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS
	-	LINKAGE ANALYSIS FOR NORMAL PROTEIN C LEVELS IN A PROTEIN C-DEFICIENT FAMILY
	-	THE EFFECT OF FLIGHT-RELATED BEHAVIOUR ON THE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL
	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
	-	PAST AND FUTURE OF GENETIC RESEARCH IN THROMBOSIS
	-	AUTO-ANTIBODIES AGAINST EPCR AND THE RISK OF A FIRST DEEP VENOUS THROMBOSIS
	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
	-	FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS
	-	HOMOCYSTEINE AND RISK FOR VENOUS THROMBOSIS IN A POPULATION-BASED PROSPECTIVE STUDY (HUNT2)
	-	MODERATE ALCOHOL CONSUMPTION DECREASES THE RISK OF VENOUS THROMBOSIS
	-	`IN VIVO' TOLL-LIKE RECEPTOR 4 MRNA LEVELS ARE ASSOCIATED WITH RISK OF MYOCARDIAL INFARCTION IN MEN
Rosenkranz A.	-	THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
	-	THROMBIN GENERATION IN OBESE CHILDREN AFTER WEIGHT REDUCTION
Rosenstein R.	-	EFFECT OF NYTROXYL AND NITRIC OXIDE ON HUMAN PLATELET ARACHIDONATE METABOLISM
	-	EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
Roshani S.	-	DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM?
Rosing J.	-	MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
	-	EFFECTS OF ORAL (OC) AND TRANSDERMAL (TC) HORMONAL CONTRACEPTION ON COAGULATION FACTORS AND ACTIVATED PROTEIN C RESISTANCE: IMPLICATIONS FOR THROMBOSIS RISK
	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	MEASUREMENT OF THROMBIN GENERATION AND APC-RESISTANCE IN MOUSE PLASMA
	-	DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING
	-	THE ROLE OF THROMBIN EXOSITES I AND II IN THE ACTIVATION OF HUMAN COAGULATION FACTOR V
	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
	-	PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA
	-	COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION
Rospide P.	-	ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES
Rosport K.	-	PR-15 A NOVEL INTRAVENOUS INHIBITOR OF PLATELET ADHESION: A PHASE I DOSE ASCENDING PHARMACOKINETIC, PHARMACODYNAMIC, AND TOLERANCE STUDY
Ross D.	-	RISK FACTORS AND OUTCOME OF THROMBOEMBOLIC EVENTS IN CHILDREN UNDERGOING CARDIAC SURGERY
Ross C.S.	-	STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
Rossetti G.	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
Rossetto V.	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
	-	INCREASED ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PATIENTS OF FAMILIES WITH INHERITED AT DEFECTS
	-	STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN 31 SUBJECTS BELONGING TO 7 FAMILIES WITH FVII DEFICIENCY
	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
Rossi L.	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
Rossi R.	-	ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY
Rossi C.	-	PROSTACYCLIN IMPROVES TRANSCORONARY MYOCARDIAL DELIVERY OF ADIPOSE TISSUE-DERIVED STROMAL CELLS
Rossi L.	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
Rossi R.	-	CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY
	-	A NEW CASE OF ACQUIRED GLANZMANN'S THROMBASTHENIA: COMPARATIVE EVALUATION OF THE DIAGNOSTIC VALUE OF DIFFERENT PLATELET FUNCTION TESTS
	-	PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY
Rossi L.	-	HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
Rossi R.	-	INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY
Rossi E.	-	EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
Rossi L.	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
Rossi R.	-	BETA-N-ACETYLHEXOSAMINIDASE (BETA-HEX), A PLATELET LYSOSOMAL ENZYME, POTENTIATES THROMBIN-INDUCED PLATELET ACTIVATION BY ACTING ON GPV
	-	DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY
Rossiello M.R.	-	IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A
	-	LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM
Rost S.	-	VKORC1: MOLECULAR TARGET OF COUMARINS
	-	IN VIVO-ASSAY FOR WARFARIN-RESISTANCE BY COEXPRESSION OF VKORC1 AND VITAMIN K-DEPENDENT COAGULATION FACTORS
Rosti V.	-	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Roth D.A.	-	REFORMULATED RECOMBINANT FACTOR IX: EFFICACY AND SAFETY IN PREVIOUSLY TREATED PATIENTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B
Rothlein R.	-	PREVENTION OF VENOUS THROMBOEMBOLISM VIA PARTIAL FACTOR IXA INHIBITION
	-	LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY
Rothschild C.	-	IMMUNE TOLERANCE IN AN ADULT AFTER A LONG TERM HISTORY OF I,HIBITOR
	-	FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
	-	THROMBOCYTOPENIA: ANALYSIS OF 317 PATIENTS
	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
Rothwell P.M.	-	LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
	-	LACK OF PREDICTIVE VALUE OF HIGH SHEAR PLATELET FUNCTION IN A POPULATION BASED COHORT STUDY OF ACUTE VASCULAR EVENTS
Rotilio D.	-	DIFFERENTIAL ANALYSIS BY 2-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS (2D-DIGE) OF HUMAN PLATELET PROTEINS RELEASED FOLLOWING THROMBIN ACTIVATION: IDENTIFICATION OF LAMIN A, A NOVEL PLATELET PROTEIN
Rotondo S.	-	INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
Rott H.	-	DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
Rott B.	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Rott H.	-	FIVE NOVEL MUTATIONS IN F13B GENE RESULTING IN MILD FXIII DEFICIENCY
	-	PAEDIATRIC REFERENCE RANGES FOR COAGULATION DIAGNOSTICS
	-	NORMAL VALUES FOR FACTOR VII ACTIVITY IN NORMAL PREGNANCY AND IN THE PREGNACY OF WOMEN WITH CONGENITAL FACTOR VII DEFICIENCY
Rottman J.B.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
Rotunno C.	-	LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM
	-	IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A
Roubey R.A.S.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
	-	ELEVATED PLASMA LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
	-	THE TRANSCRIPTION FACTOR EGR-1 PLAYS A CRITICAL ROLE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS
Roumen-Klappe E.M.	-	ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME
	-	COMPRESSION BANDAGING IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS IN RELATION TO THE POST-THROMBOTIC SYNDROME
Roumeque L.	-	THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
Roupie E.	-	PULMONARY EMBOLISM DIAGNOSTIC TOOLS IN FRENCH EMERGENCY DEPARTMENTS: AVAILABILITY INCREASES BUT PHYSICIAN KNOWLEDGE REMAINS POOR
Rousseau A.	-	HAEMOSTASIS DISTURBANCES IN TYPE I AND II DIABETES MELLITUS
	-	DETECTION OF HYPERCOAGULABILITY IN PATIENTS WITH THYROID CANCER
	-	A FUNCTIONAL AUTOMATED ASSAY FOR THROMBOMODULIN ACTIVITY IN PLASMA
	-	EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
	-	HIGH CONCENTRATION OF PROCOAGULANT PHOSPHOLIPIDS AND THROMBOMODULIN ACTIVITY ARE FOUND IN PREGNANCY COMPLICATIONS
Roussel B.	-	SERIOUS BLEEDS IN HAEMOPHILIAC A CHILDREN AND CONTINUOUS INFUSION (CI)
Roussel-Robert V.	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
Roussin A.	-	PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
Rouvier E.	-	PERFORMANCES OF A NEW ELISA (ZYMUTEST HIA) FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Roux A.	-	RISK FACTORS AND CLINICAL SIGNIFICANCE OF RESIDUAL PERFUSION DEFECTS AFTER SYMPTOMATIC PULMONARY EMBOLISM
Rovira M.	-	ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Rowaichi A.	-	TRENDS IN FVIII AND FIX USE IN THE UNITED KINGDOM 2001-2006
Rowe J.M.	-	ADAMTS-13 ACTIVITY, ANTIGEN AND INHIBITOR ANTIBODIES IN TTP PATIENTS A SINGLE CENTER EXPERIENCE
Roy P.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
Roy A.	-	THE EFFECT OF THE SUGARBAKER PROCEDURE ON HAEMOSTASIS
Roy P.	-	MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
Roy A.	-	AUDIT OF SCREENING FOR VON WILLEBRANDS DISEASE AND PLATELET FUNCTION ABNORMALITIES USING THE PFA-100
	-	IMMUNE-TOLERANCE IN HAEMOPHILIA A USING PLASMA-DERIVED FACTOR VIII CONCENTRATE FANHDI
Roy P.	-	PULMONARY EMBOLISM DIAGNOSTIC TOOLS IN FRENCH EMERGENCY DEPARTMENTS: AVAILABILITY INCREASES BUT PHYSICIAN KNOWLEDGE REMAINS POOR
Rozenberg P.	-	CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Rozenshteyn D.	-	MECHANISMS OF INACTIVATION OF COAGULATION FACTOR VIIIA BY ACTIVATED PROTEIN C WITH PROTEIN S
Rozmanc M.	-	INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
Ruan C.	-	PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
	-	HYPERFIBRINOLYTIC STATE IN ACUTE PROMYELOCYTIC LEUKEMIA ASSOCIATED WITH DISSEMINATED INTRAVASCULAR COAGULATION
	-	EXPRESSION OF MT1-MMP IN HUMAN VASCULAR ENDOTHELIAL CELL LINES AND THE CONSTRUCTION OF ITS EUKARYOTIC EXPRESSION VECTOR
	-	A HETEROZYGOUS MUTATION OF GPIIB IN PATIENT WITH GLANZMANN THROMBASTHENIA
	-	VEGF-C PROMOTE OF THE GROWTH AND ANGIOGENESIS IN NB4 CELL XENOGRAFT TUMOR
	-	FUNCTIONAL IN VITRO CHARACTERIZATION OF A NOVEL ADAMTS13 MUTATION (R1095W) AND POLYMORPHISM (S903L)
	-	QUANTITATIVE ANALYSIS OF GENE EXPRESSION FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS APPLICATION
	-	CROSS REACTION OF ANTIBODY AGAINST HELICOBACTER PYLORI UREASE B WITH PLATELET GLYCOPROTEIN IIIA AND ITS SIGNIFICANCE IN THE PATHOGENESIS OF ITP
	-	TWO NOVEL MONOCLONAL ANTIBODIES TO VWFA3 INHIBIT VWF-COLLAGEN AND VWFPLATELET GPIB INTERACTIONS
	-	ALTERATIONS OF HEMOSTATIC PARAMETERS IN PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Ruan C.G.	-	STUDY OF ANTI-ANGIOGENESIS EFFECT INDUCED BY MER IN VITRO AND ITS MECHANISM
Ruano M.	-	EPINEPHRINE REDUCES THE EFFECT OF ANTIPLATELET THERAPIES IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS). ROLE OF PI3K
	-	INSUFFICIENT INHIBITION OF PLATELET THROMBOXANE SYNTHESIS IS ASSOCIATED WITH GREATER CORONARY ARTERY DISEASE EVALUATED BY ANGIOGRAPHY
Rubin M.S.	-	ANALYSIS OF THE GENETIC EXPRESSION OF INFLAMMATORY MEDIATORS IN MONONUCLEAR CELLS FROM DEEP VENOUS THROMBOSIS PATIENTS
Rubin-Asher D.	-	THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
Rubini C.	-	TF EXPRESSION IN HUMAN PLACENTA IS SIGNIFICANTLY ASSOCIATED WITH VEGF EXPRESSION
Ruchutrakool T.	-	THE CORRELATION OF SERUM FERRITIN AND PLATELET ACTIVATION IN BETA-THALASSEMIA MAJOR
	-	INTRACRANIAL AND SPINAL HEMORRHAGE IN ADULT HEMOPHILIA A IN SIRIRAJ HOSPITAL, THAILAND
Rud Lassen M.	-	DETECTION OF HYPERCOAGULABILITY IN HIP ARTHROPLASTY PATIENTS BY REPEATED MEASSUREMENTS OF URINE PROTHROMBIN FRAGMENT 1.2
Ruda M.Y.	-	THE INCREASE OF INFLAMMATORY MARKERS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IS NOT AFFECTED BY GLYCOPROTEIN IIB-IIIA ANTAGONIST EPTIFIBATIDE
Rudelius M.	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
Rudez G.	-	EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS
	-	PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
Rudin K.	-	EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
Ruf A.	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Ruf W.	-	TISSUE FACTOR DEPENDENT INITIATION OF PLATELET AND FIBRIN THROMBUS FORMATION
	-	THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES
	-	PDI CHAPERONE FUNCTION ENHANCES TF PROCOAGULANT ACTIVITY
Ruffatti A.	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
	-	THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
Rugal V.I.	-	REGULATION OF DEVELOPMENT AND FUNCTION ENDOTHELIAL CELLS BY XENOGENIC IMMUNOGLOBULINS
Rugeri L.	-	CONTRIBUTION OF GENETIC ANALYSIS FOR DIAGNOSIS OF VON WILLEBRAND DISEASE TYPE 2B
	-	ASSESSMENT OF A METHOD BASED ON LUMINESCENCE DETECTION FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
	-	EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
	-	THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE
Ruggeri Z.M.	-	THE FUNCTION OF GLYCOPROTEIN IB
	-	THE ROLE OF PLATELET GLYCOPROTEIN VI IN ARTERIAL THROMBOSIS
	-	MODULATION OF VON WILLEBRAND A1 DOMAIN FUNCTION BY THE HOMOLOGOUS DOMAINS A2 AND A3
	-	TISSUE FACTOR DEPENDENT INITIATION OF PLATELET AND FIBRIN THROMBUS FORMATION
	-	THROMBIN BINDING TO GLYCOPROTEIN IB ALPHA ON PLATELETS INVOLVES EXOSITE I
	-	SPATIO-TEMPORAL CALCIUM SIGNALING ELICITED BY INTEGRIN ALPHA2-BETA1 AND GLICOPROTEIN VI UNDER FLOW
	-	BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
Ruggeri M.	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Ruggeri Z.M.	-	KLF4, A MODIFIER GENE IN GP6-NULL MICE
	-	PROTEOLYSIS-INDEPENDENT ENHANCEMENT OF ARTERIAL THROMBOSIS MEDIATED BY THROMBIN BINDING TO GLYCOPROTEIN IB AND VON WILLEBRAND FACTOR
	-	ROLE OF DISTINCT AMINO ACID RESIDUES IN THE INTERACTION OF SOLUBLE OR SURFACE-BOUND VON WILLEBRAND FACTOR A1 DOMAIN WITH PLATELETS
	-	EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
	-	GLYCOPROTEIN IB ALPHA BINDS THROMBIN VIA TO BOTH EXOSITE I AND II OF THROMBIN
Ruggeri L.	-	PLATELET-DERIVED NITRIC OXIDE CONTRIBUTE TO THE REGULATION OF BLOOD PRESSURE IN MICE
Rühlmann C.	-	THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
Ruiz M.	-	RITUXIMAB TREATMENT FOR MILD HEMOPHILIA A WITH INHIBITORS
Ruiz-Espejo F.	-	ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY
Ruiz-Saez A.	-	USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS
Rukavitsin O.A.	-	REGULATION OF DEVELOPMENT AND FUNCTION ENDOTHELIAL CELLS BY XENOGENIC IMMUNOGLOBULINS
Rumi M.G.	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
Rumley A.	-	COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY
	-	LOW ADAMTS13 LEVELS INCREASE THE RISK OF MYOCARDIAL INFARCTION (MI) INDEPENDENTLY OF VON WILLEBRAND FACTOR: GLASGOW MI STUDY
Rumsh L.	-	DIRECT PROTECTIVE EFFECT OF ACTIVATED PROTEIN C ON MAST CELLS DEGRANULATION
Rupin A.	-	NOX4 IS STRONGLY INVOLVED IN ENDOTHELIAL PAI-1 SYNTHESIS
	-	ANTITHROMBOTIC ACTIVITY OF THE TP-RECEPTOR ANTAGONIST TERUTROBAN ON FOLTS-LIKE AND FECL3 INDUCED RAT MODELS OF THROMBOSIS
Rusanova A.V.	-	PAR1 AGONISTS ACCELERATE ULCER HEALING IN RATS
Rusen L.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
	-	ACUTE CORONARY STENT THROMBOSIS IN A PATIENT WITH SEVERE HAEMOPHILIA ON DUAL ANTIPLATELET THERAPY
Russell D.B.	-	POST-THROMBOTIC SYNDROME (PTS) AFTER TOTAL HIP REPLACEMENT (THR): INCIDENCE AND CORRELATES
Russo L.	-	ALL-TRANS RETINOIC ACID (ATRA) INHIBITS ENDOTHELIAL ANGIOGENESIS INDUCED BY TUMOR CELLS AND STANDARD FACTORS
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) DALTEPARIN REDUCES THE PROTHROMBOTIC AND PROANGIOGENIC POTENTIAL OF MICROVASCULAR ENDOTHELIAL CELLS ELICITED BY TUMOR CELLS
	-	DIFFERENTIAL EFFECTS OF RETINOIDS ON THE PROCOAGULANT ACTIVITY (PCA) AND CYTO-DIFFERENTIATION OF LEUKEMIC CELLS FRESHLY ISOLATED FROM ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS
Russo U.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Russo L.	-	PROGNOSTIC SIGNIFICANCE FOR VENOUS THROMBOEMBOLISM (VTE) OF HEMOSTATIC MARKERS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
	-	THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
Russo J.	-	SIGNIFICANT REDUCTION OF VASCULAR GRAFT OCCLUSIONS IN CHRONIC HEMODIALYSIS PATIENTS WITH PEG-HIRUDIN (SPP200)
Rutskina E.A.	-	CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING
	-	LYMPHOCYTE-PLATELET ADHESION IN PATIENTS WITH ANGINA PECTORIS
Rutten P.M.	-	RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS
Ruven H.	-	IL 1A 899C/T AND IL4 589C/T ARE ASSOCIATED WITH VENOUS THROMBOEMBOLISM
Rux A.H.	-	THE COOPERATIVE ACTIVITY OF THE MIDDLE AND DISTAL CARBOXYL TERMINAL DOMAINS OF ADAMTS13 IS CRUCIAL FOR BINDING VON WILLEBRAND FACTOR UNDER FLOW
Ruzza L.	-	SUBMASSIVE PULMONARY EMBOLISM: ROLE OF THROMBOLITIC THERAPY
Ryabchenko A.M.	-	LYMPHOCYTE PLATELET ADHESION IN THROMBOPHILIC PATIENTS WITH LUNG SURGERY
Ryabysh E.	-	D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS
Ryban L.	-	ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
Rydén L.	-	NO EFFECT OF LIPID LOWERING BY SIMVASTATIN OR SIMVASTATIN AND EZETIMIBE ON PLATELET FUNCTION IN PATIENTS WITH TYPE 2 DIABETES OR IMPAIRED GLUCOSE TOLERANCE AND CORONARY ARTERY DISEASE
Ryge C.	-	DEVELOPMENT OF A NOVEL ONE STEP LATERAL FLOW DEVISE FOR QUALITATIVE DETECTION OF PROTHROMBIN FRAGMENT F1+2 IN URINE
	-	DETECTION OF HYPERCOAGULABILITY IN HIP ARTHROPLASTY PATIENTS BY REPEATED MEASSUREMENTS OF URINE PROTHROMBIN FRAGMENT 1.2
Ryu C.	-	ANTIPROLIFERATIVE ACTIVITY OF YQN1, A NEWLY SYNTHESIZED INDOLEDIONE DERIVATIVE, ON PDGF-BB-STIMULATED AORTIC VASCULAR SMOOTH MUSCLE CELLS
Ryzhak A.P.	-	SPECIFIC PHENOTYPE OF PLATELETS GPIB, GPIIB, GPIIIA AND GMP-140 IN PATIENTS WITH LOW LIMB VARICOSE VEIN DISEASE

| ISTH 2009